Alzheimer’s Disease Amyloid β-Protein and Synaptic Function

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Neuromolecular medicine

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12017-009-8091-0PMID 19757208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity.

  2011cited by this paper
• Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.

  2011cited by this paper
• Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine.

  2011influential reference
• ß-amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices.

  2010cited by this paper
• Nicotinic Acetylcholine Receptors

  2010cited by this paper
• Excitatory Amino Acids.

  2010cited by this paper
• Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

  2009influential reference
• Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.

  2009cited by this paper
• Intracellular mechanisms underlying the nicotinic enhancement of LTP in the rat dentate gyrus

  2009cited by this paper
• Bridging physiology and pathology in AD.

  2009cited by this paper
• Synaptic Retrogenesis and Amyloid-β in Alzheimer's Disease

  2009cited by this paper
• Mg2+ Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine

  2009influential reference
• RAGE and Alzheimer's Disease: A Progression Factor for Amyloid-β-Induced Cellular Perturbation?

  2009cited by this paper
• Memory performance is related to amyloid and tau pathology in the hippocampus

  2009cited by this paper
• Deletion of the α7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease

  2009influential reference
• Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers

  2009cited by this paper
• A Role for Synaptic Zinc in Activity-Dependent Aβ Oligomer Formation and Accumulation at Excitatory Synapses

  2009cited by this paper
• Contribution of neural networks to Alzheimer disease's progression.

  2009cited by this paper
• Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice.

  2009cited by this paper
• Synaptic degeneration in Alzheimer’s disease

  2009cited by this paper
• Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice

  2009cited by this paper
• Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.

  2009cited by this paper
• Amyloid β‐protein fragments 25–35 and 31–35 potentiate long‐term depression in hippocampal CA1 region of rats in vivo

  2009cited by this paper
• Faculty Opinions recommendation of Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.

  2009influential reference
• β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic Distribution*

  2009cited by this paper
• Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.

  2009cited by this paper
• P4‐213: Stereospecific interactions are necessary for Alzheimer's disease amyloid‐beta toxicity

  2009cited by this paper
• Role of Amyloid-β Glycine 33 in Oligomerization, Toxicity, and Neuronal Plasticity

  2009cited by this paper
• Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus

  2008influential reference
• Aromatic residues at position 55 of rat α7 nicotinic acetylcholine receptors are critical for maintaining rapid desensitization

  2008cited by this paper
• Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008influential reference
• Soluble amyloid-beta peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo.

  2008influential reference
• Alpha4beta2 nicotinic acetylcholine receptors are required for the amyloid beta protein-induced suppression of long-term potentiation in rat hippocampal CA1 region in vivo.

  2008cited by this paper
• Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades.

  2008cited by this paper
• αv integrins mediate beta-amyloid induced inhibition of long-term potentiation

  2008cited by this paper
• Aβ1–42 modulation of Akt phosphorylation via α7 nAChR and NMDA receptors

  2008cited by this paper
• Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization

  2008cited by this paper
• Preclinical Characterization of A‐582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition‐Enhancing Properties

  2008cited by this paper
• Alpha v integrins mediate beta-amyloid induced inhibition of long-term potentiation.

  2008cited by this paper
• Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model

  2008cited by this paper
• Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction

  2008cited by this paper
• Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?

  2008cited by this paper
• Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease

  2008cited by this paper
• Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.

  2008cited by this paper
• Endogenous secreted amyloid precursor protein-alpha regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory.

  2008cited by this paper
• Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice.

  2008cited by this paper
• Modulation of Hippocampus-Dependent Learning and Synaptic Plasticity by Nicotine

  2008cited by this paper
• Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning.

  2008influential reference
• Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats

  2008cited by this paper
• Mg2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes

  2008cited by this paper
• BACE1 Knock-Outs Display Deficits in Activity-Dependent Potentiation of Synaptic Transmission at Mossy Fiber to CA3 Synapses in the Hippocampus

  2008cited by this paper
• Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease

  2008cited by this paper
• Abeta(1-42) modulation of Akt phosphorylation via alpha7 nAChR and NMDA receptors.

  2008cited by this paper
• Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic Impairment

  2008cited by this paper
• SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (1) Binding and Functional Profile

  2007cited by this paper
• [Pathogenesis of Alzheimer disease].

  2007cited by this paper
• The Secreted β-Amyloid Precursor Protein Ectodomain APPsα Is Sufficient to Rescue the Anatomical, Behavioral, and Electrophysiological Abnormalities of APP-Deficient Mice

  2007cited by this paper
• Compartmentalized NMDA receptor signalling to survival and death

  2007cited by this paper
• NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

  2007cited by this paper
• Pathologically activated therapeutics for neuroprotection

  2007influential reference
• α2β1 and αVβ1 integrin signaling pathways mediate amyloid-β-induced neurotoxicity

  2007cited by this paper
• Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activity

  2007cited by this paper
• High content screen microscopy analysis of A beta 1-42-induced neurite outgrowth reduction in rat primary cortical neurons: neuroprotective effects of alpha 7 neuronal nicotinic acetylcholine receptor ligands.

  2007cited by this paper
• Pathologically activated therapeutics for neuroprotection

  2007cited by this paper
• Amyloid beta protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors.

  2007cited by this paper
• Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

  2007cited by this paper
• Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-D-aspartate receptor subunits.

  2007cited by this paper
• Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice.

  2007cited by this paper
• Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine*

  2007cited by this paper
• Glutamatergic synaptic depression by synthetic amyloid β‐peptide in the medial septum

  2007cited by this paper
• Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death.

  2007cited by this paper
• Alpha2beta1 and alphaVbeta1 integrin signaling pathways mediate amyloid-beta-induced neurotoxicity.

  2007cited by this paper
• A brief, but repeated, swimming protocol is sufficient to overcome amyloid β‐protein inhibition of hippocampal long‐term potentiation

  2007influential reference
• Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

  2007cited by this paper
• Involvement of β-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity

  2007cited by this paper
• Beta-amyloid blocks high frequency stimulation induced LTP but not nicotine enhanced LTP.

  2007cited by this paper
• Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.

  2007cited by this paper
• Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.

  2007influential reference
• Modulation of synaptic plasticity by physiological activation of M[1] muscarinic acetylcholine receptors in the mouse hippocampus

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• β-Amyloid-induced Dynamin 1 Degradation Is Mediated by N-Methyl-D-Aspartate Receptors in Hippocampal Neurons*

  2006cited by this paper
• The role of nicotinic acetylcholine receptors in Alzheimer's disease.

  2006cited by this paper
• The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

  2006cited by this paper
• Nicotinic receptor‐mediated enhancement of long‐term potentiation involves activation of metabotropic glutamate receptors and ryanodine‐sensitive calcium stores in the dentate gyrus

  2006cited by this paper
• The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• Unraveling in vivo Functions of Amyloid Precursor Protein: Insights from Knockout and Knockdown Studies

  2006cited by this paper
• Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.

  2006cited by this paper
• alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.

  2006cited by this paper
• α7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in β-amyloid infused rats

  2006cited by this paper
• Nicotinic Acetylcholine Receptors at Glutamate Synapses Facilitate Long-Term Depression or Potentiation

  2005cited by this paper
• Modulation of Synaptic Plasticity by Physiological Activation of M1 Muscarinic Acetylcholine Receptors in the Mouse Hippocampus

  2005influential reference
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.

  2005cited by this paper
• Globular amyloid β‐peptide1−42 oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease

  2005cited by this paper
• Divergent effects of Aβ1–42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-β

  2005influential reference

• Oxiracetam Improves Cognitive Disorder in AD by Modulating AMPAR Subunits GluA1/GluA2 Kinetics.

  2026cites this paper
• Divergent disruptive effects of soluble recombinant tau assemblies on synaptic plasticity in vivo

  2025cites this paper
• Blockage of CCL3 with neutralizing antibody reduces neuroinflammation and reverses Alzheimer disease phenotypes.

  2025cites this paper
• Teucrium Polium ameliorates amyloid β-induced brain network disorders in rats: electrophysiological and behavioral studies

  2025cites this paper
• Delphinidin: A Multifaceted Anthocyanidin With Therapeutic Potential in Chronic Diseases

  2025cites this paper
• PP2A methylesterase, PME‐1, and PP2A methyltransferase, LCMT‐1, control sensitivity to impairments caused by injury‐related oligomeric tau

  2025cites this paper
• Development of Neurodegenerative Disease Diagnosis and Monitoring from Traditional to Digital Biomarkers

  2025cites this paper
• A combination of Δ9-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease

  2024cites this paper
• An evaluation study on screening, partial purification, and characterization of proteins and antioxidant peptides from two varieties of Clitoria Ternatea.

  2024cites this paper
• Patient-derived tau and amyloid-β facilitate long-term depression in vivo: role of tumour necrosis factor-α and the integrated stress response

  2024cites this paper
• Serotonergic Neuromodulation of Synaptic Plasticity.

  2024cites this paper
• Navβ2 Intracellular Fragments Contribute to Aβ1-42-Induced Cognitive Impairment and Synaptic Deficit Through Transcriptional Suppression of BDNF

  2024cites this paper
• Early and late chaperone intervention therapy boosts XBP1s and ADAM10, restores proteostasis, and rescues learning in Alzheimer's Disease mice.

  2023cites this paper
• mGluR-dependent plasticity in rodent models of Alzheimer’s disease

  2023cites this paper
• Differential vulnerability of hippocampal CA3-CA1 synapses to Aβ

  2022cites this paper
• Electrochemical aptamer-based nanobiosensors for diagnosing Alzheimer's disease: A review.

  2022cites this paper
• Modulation of Amyloid β-Induced Microglia Activation and Neuronal Cell Death by Curcumin and Analogues

  2022cites this paper
• Biophysical characterization as a tool to predict amyloidogenic and toxic properties of amyloid‐β42 peptides

  2022cites this paper
• ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease

  2022cites this paper
• Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities

  2022cites this paper
• Alzheimer's Disease and Protein Kinases.

  2021cites this paper
• Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter Alterations

  2021cites this paper
• The Density of Group I mGlu5 Receptors Is Reduced along the Neuronal Surface of Hippocampal Cells in a Mouse Model of Alzheimer’s Disease

  2021cites this paper
• Roles and Mechanisms of the Protein Quality Control System in Alzheimer’s Disease

  2021cites this paper
• Chemical similarity assisted search for acetylcholinesterase inhibitors: Molecular modeling and evaluation of their neuroprotective properties.

  2021cites this paper
• Developmental synaptic regulator, TWEAK/Fn14 signaling, is a determinant of synaptic function in models of stroke and neurodegeneration

  2021cites this paper
• Reduced Expression of the PP2A Methylesterase, PME-1, or the PP2A Methyltransferase, LCMT-1, Alters Sensitivity to Beta-Amyloid-Induced Cognitive and Electrophysiological Impairments in Mice

  2020cites this paper
• Spatial memory deficits initiated by agroclavine injection or olfactory bulbectomy in rats are characterized by different levels of long-term potentiation expression in the hippocampus

  2020cites this paper
• Physical Stress Induced Reduction of Proliferating Cells and Differentiated Neuroblasts Is Ameliorated by Fermented Laminaria japonica Extract Treatment

  2020cites this paper
• Electrophysiological and Imaging Calcium Biomarkers of Aging in Male and Female 5×FAD Mice

  2020cites this paper
• Neuroscientific Research for Management of Dementia

  2019cites this paper
• Effect of Riluzole, a Glutamate Release Inhibitor, on Synaptic Plasticity in the Intrahippocampal Aβ Rat Model of Alzheimer’s Disease

  2019cites this paper
• Post-tetanic Potentiation and Depression in Hippocampal Neurons in a Rat Model of Alzheimer’s Disease: Effects of Teucrium Polium Extract

  2019cites this paper
• Full recovery of the Alzheimer’s disease phenotype by gain of function of Vacuolar Protein Sorting 35

  2019cites this paper
• Soluble tau aggregates inhibit synaptic long-term depression and amyloid β-facilitated LTD in vivo.

  2019cites this paper
• The anaesthetic xenon partially restores an amyloid beta‐induced impairment in murine hippocampal synaptic plasticity

  2019cites this paper
• The role of TGF-&bgr; superfamily signaling in neurological disorders

  2018cites this paper
• Tokishakuyakusan ameliorates spatial memory deficits induced by ovariectomy combined with β-amyloid in rats.

  2018cites this paper
• Downregulation of autophagy by 12/15Lipoxygenase worsens the phenotype of an Alzheimer’s disease mouse model with plaques, tangles, and memory impairments

  2018cites this paper
• Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches.

  2018cites this paper
• High-frequency (50 Hz) electroacupuncture ameliorates cognitive impairment in rats with amyloid beta 1–42-induced Alzheimer's disease

  2018cites this paper
• Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer's disease model.

  2018cites this paper
• Mechanisms and modulators of cognitive training gain transfer in cognitively healthy aging: study protocol of the AgeGain study

  2018cites this paper
• The modulatory role of phloretin in Aβ25–35 induced sporadic Alzheimer’s disease in rat model

  2018cites this paper
• Susceptibility to Aβo and TBOA of LTD and Extrasynaptic NMDAR-Dependent Tonic Current in the Aged Rat Hippocampus

  2018cites this paper
• A preclinical screen to evaluate pharmacotherapies for the treatment of agitation in dementia

  2017cites this paper
• Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer ' s Disease : Pharmacological and stem cells approaches

  2017cites this paper
• Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer’s disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid

  2017cites this paper
• Learning-Related Hippocampal Long-Term Potentiation and Long-Term Depression

  2017cites this paper
• Acyl ghrelin improves cognition, synaptic plasticity deficits and neuroinflammation following amyloid β (Aβ1‐40) administration in mice

  2017cites this paper
• Modulation of AβPP and GSK3β by Endoplasmic Reticulum Stress and Involvement in Alzheimer’s Disease

  2017cites this paper
• Chronic Monoarthritis Pain Accelerates the Processes of Cognitive Impairment and Increases the NMDAR Subunits NR2B in CA3 of Hippocampus from 5-month-old Transgenic APP/PS1 Mice

  2017cites this paper
• Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice

  2017cites this paper
• Computational investigation of Amyloid-β-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer’s disease

  2017cites this paper
• G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channel Activation by the p75 Neurotrophin Receptor Is Required for Amyloid β Toxicity

  2017cites this paper
• Roles for Arc in metabotropic glutamate receptor-dependent LTD and synapse elimination: Implications in health and disease.

  2017cites this paper
• Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease

  2017cites this paper
• SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.

  2017cites this paper
• Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer's disease

  2017cites this paper
• Mesenchymal Stem Cells of Dental Origin-Their Potential for Anti-inflammatory and Regenerative Actions in Brain and Gut Damage

  2016cites this paper
• Age‐related synaptic dysfunction in Tg2576 mice starts as a failure in early long‐term potentiation which develops into a full abolishment of late long‐term potentiation

  2016cites this paper
• The 5‐hydroxytryptamine4 receptor enables differentiation of informational content and encoding in the hippocampus

  2016cites this paper
• The aging memory: Modulating epigenetic modifications to improve cognitive function.

  2016cites this paper
• Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer's Disease

  2016cites this paper
• Neurogranin restores amyloid β-mediated synaptic transmission and long-term potentiation deficits.

  2016cites this paper
• PP2A methylation controls sensitivity and resistance to β-amyloid–induced cognitive and electrophysiological impairments

  2016cites this paper
• Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.

  2015cites this paper
• How dependent is synaptic plasticity on microglial phenotype?

  2015cites this paper
• Long-term Dantrolene Treatment Reduced Intraneuronal Amyloid in Aged Alzheimer Triple Transgenic Mice

  2015cites this paper
• Traumatic Brain Injury, Chronic Traumatic Encephalopathy, and Alzheimer’s Disease: Common Pathologies Potentiated by Altered Zinc Homeostasis

  2015cites this paper
• Supporting evidence for using Perispinal Etanercept to inhibit TNF&agr; when treating neuropathologies including dementia, chronic stroke, neuropathic pain or traumatic brain injury: Role of TNF in neuropathologies and in particular in Alzheimer's disease (Part II)

  2015cites this paper
• A Chromatography based interaction analysis of two important biomolecules: neurotoxic Amyloid beta oligomers and human blood plasma proteins -

  2015cites this paper
• OVEREXPRESSION OF CLATHRIN IN HIPPOCAMPUS OF ALZHEIMER'S DISEASE RAT TREATED WITH LAVANDULA ANGUSTIFOLIA

  2015cites this paper
• Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer’s disease immunotherapeutics

  2014cites this paper
• Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.

  2014cites this paper
• GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease

  2014cites this paper
• Impairments in experience‐dependent scaling and stability of hippocampal place fields limit spatial learning in a mouse model of Alzheimer's disease

  2014cites this paper
• Dangerous liaisons between beta-amyloid and cholinergic neurotransmission.

  2014cites this paper
• The proline-rich hypothalamic peptide is a modulator of functions of neurotrophins and neuronal activity in amyloid-induced neurodegeneration

  2014cites this paper
• Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo

  2014cites this paper
• Glutamatergic Receptors in Parkinson’s Disease

  2014cites this paper
• Neuroprotective effects of Eriobotrya japonica and Salvia miltiorrhiza Bunge in in vitro and in vivo models

  2014cites this paper
• Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease.

  2014influential citation
• Positron Emission Tomography Molecular Imaging in Late-Life Depression

  2014influential citation
• The role of endoplasmic reticulum in amyloid precursor protein processing and trafficking: implications for Alzheimer's disease.

  2014cites this paper
• Orally bioavailable small molecule drug protects memory in Alzheimer's disease models.

  2013cites this paper
• Tackling the elusive challenges relevant to conquering the 100-plus year old problem of Alzheimer's disease.

  2013cites this paper
• Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow

  2013cites this paper
• Ageing as a Trait de Union between diabetes and dementia for frailty.

  2013cites this paper
• Dietary cholesterol increases ventricular volume and narrows cerebrovascular diameter in a rabbit model of Alzheimer's disease.

  2013cites this paper
• CUL1 promotes trophoblast cell invasion at the maternal–fetal interface

  2013cites this paper
• Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer’s Disease: Dissociation between Somatosensory Cortex and Hippocampus

  2013cites this paper
• Dietary cholesterol degrades rabbit long term memory for discrimination learning but facilitates acquisition of discrimination reversal.

  2013cites this paper
• Frailty among Alzheimer's disease patients.

  2013cites this paper
• Amyloid Beta Peptides Differentially Affect Hippocampal Theta Rhythms In Vitro

  2013cites this paper
• NMDA receptors in nervous system diseases.

  2013cites this paper
• Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?

  2013cites this paper
• Lycopersicon esculentum Miller: from by-products towards neuroprotection

  2013cites this paper
• FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats

  2013cites this paper
• Cell adhesion molecules in Alzheimer's disease.

  2012cites this paper